Literature DB >> 25586536

Immunological differences between classical phenothypes of multiple sclerosis.

Piotr Iwanowski1, Jacek Losy2.   

Abstract

Multiple sclerosis (MS), one of the most serious inflammatory and neurodegenerative conditions, is characterized by variable clinical courses - relapsing-remitting (RRMS), primary progressive (PPMS) and secondary progressive (SPMS). Although PPMS affects only 10-15% of the patient population, its course and pathophysiological and immunological background are distinct. In this review we present and discuss main differences between different types of MS, with particular focus on the underlying immunological mechanisms.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adhesion molecules; AntiGM3 antibodies; Demyelination; Neurodegeneration; PPMS; Primary progressive multiple sclerosis

Mesh：

Year:  2015        PMID： 25586536     DOI： 10.1016/j.jns.2014.12.035

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN： 0022-510X            Impact factor:   3.181


  11 in total

Review 1.  A focus on secondary progressive multiple sclerosis (SPMS): challenges in diagnosis and definition.

Authors:  Hernan Inojosa; Undine Proschmann; Katja Akgün; Tjalf Ziemssen
Journal:  J Neurol       Date:  2019-07-30       Impact factor: 4.849

Review 2.  Polymorphisms in miRNA genes and their involvement in autoimmune diseases susceptibility.

Authors:  Andrea Latini; Cinzia Ciccacci; Giuseppe Novelli; Paola Borgiani
Journal:  Immunol Res       Date:  2017-08       Impact factor: 2.829

3.  Population Pharmacokinetics of Daclizumab High-Yield Process in Healthy Volunteers and Subjects with Multiple Sclerosis: Analysis of Phase I-III Clinical Trials.

Authors:  Lei Diao; Yaming Hang; Ahmed A Othman; Ivan Nestorov; Jonathan Q Tran
Journal:  Clin Pharmacokinet       Date:  2016-08       Impact factor: 6.447

Review 4.  A review of genome-wide association studies for multiple sclerosis: classical and hypothesis-driven approaches.

Authors:  V V Bashinskaya; O G Kulakova; A N Boyko; A V Favorov; O O Favorova
Journal:  Hum Genet       Date:  2015-09-25       Impact factor: 4.132

5.  The genetic diversity of multiple sclerosis risk among Hispanic and African American populations living in the United States.

Authors:  A H Beecham; L Amezcua; A Chinea; C P Manrique; C Rubi; N Isobe; B T Lund; A Santaniello; G W Beecham; E G Burchard; M Comabella; N Patsopoulos; K Fitzgerald; P A Calabresi; P De Jager; D V Conti; S R Delgado; J R Oksenberg; J L McCauley
Journal:  Mult Scler       Date:  2019-08-01       Impact factor: 5.855

Review 6.  Evaluation of Study and Patient Characteristics of Clinical Studies in Primary Progressive Multiple Sclerosis: A Systematic Review.

Authors:  T Ziemssen; S Rauer; C Stadelmann; T Henze; J Koehler; I-K Penner; M Lang; D Poehlau; M Baier-Ebert; H Schieb; S Meuth
Journal:  PLoS One       Date:  2015-09-22       Impact factor: 3.240

7.  Th1 and Th17 Cells and Associated Cytokines Discriminate among Clinically Isolated Syndrome and Multiple Sclerosis Phenotypes.

Authors:  Gabriel Arellano; Eric Acuña; Lilian I Reyes; Payton A Ottum; Patrizia De Sarno; Luis Villarroel; Ethel Ciampi; Reinaldo Uribe-San Martín; Claudia Cárcamo; Rodrigo Naves
Journal:  Front Immunol       Date:  2017-06-30       Impact factor: 7.561

Review 8.  Interferons and Multiple Sclerosis: Lessons from 25 Years of Clinical and Real-World Experience with Intramuscular Interferon Beta-1a (Avonex).

Authors:  Stanley L Cohan; Barry A Hendin; Anthony T Reder; Kyle Smoot; Robin Avila; Jason P Mendoza; Bianca Weinstock-Guttman
Journal:  CNS Drugs       Date:  2021-07-06       Impact factor: 5.749

Review 9.  Pathogenesis of autoimmune demyelination: from multiple sclerosis to neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody-associated disease.

Authors:  Joseph A Lopez; Martina Denkova; Sudarshini Ramanathan; Russell C Dale; Fabienne Brilot
Journal:  Clin Transl Immunology       Date:  2021-07-26

10.  Variants of MicroRNA Genes: Gender-Specific Associations with Multiple Sclerosis Risk and Severity.

Authors:  Ivan Kiselev; Vitalina Bashinskaya; Olga Kulakova; Natalia Baulina; Ekaterina Popova; Alexey Boyko; Olga Favorova
Journal:  Int J Mol Sci       Date:  2015-08-24       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.